DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 1NanoAlvand
03 1Naprod Life Sciences
04 2Acrotech Biopharma
05 4Mundipharma
06 1Servier Canada
07 2Teva Pharmaceutical Industries
01 2INJECTABLE;INJECTION
02 1Liquid Injection
03 1SOLUTION
04 4SOLUTION;INTRAVENOUS
05 1Vial
06 4Blank
01 1Prescription
02 4RX
03 8Blank
01 3FOLOTYN
02 4Folotyn
03 4PRALATREXATE
04 1Pralym
05 1Blank
01 4Australia
02 1Canada
03 1India
04 1Iran
05 6USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PRALATREXATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 20MG/ML (20MG/ML)
Packaging :
Approval Date : 2025-03-10
Application Number : 206183
Regulatory Info : RX
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Pralym
Dosage Form : Vial
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Liquid Injection
Dosage Strength : 20MG/ML
Packaging : 1 ml and 2 ml pack
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PRALATREXATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 40MG/2ML (20MG/ML)
Packaging :
Approval Date : 2025-03-10
Application Number : 206183
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOLOTYN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 20MG/ML (20MG/ML)
Packaging :
Approval Date : 2009-09-24
Application Number : 22468
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOLOTYN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 40MG/2ML (20MG/ML)
Packaging :
Approval Date : 2009-09-24
Application Number : 22468
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Australia
Brand Name : Folotyn
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Folotyn
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Folotyn
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Folotyn
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : FOLOTYN
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging : 1ML VIAL
Approval Date :
Application Number : 2481820
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : USA
Brand Name : PRALATREXATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/1ML
Packaging :
Approval Date :
Application Number : 206167
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PRALATREXATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 40MG/2ML
Packaging :
Approval Date :
Application Number : 206167
Regulatory Info :
Registration Country : USA
